Denise Bronner, Ph.D., makes the case for and against acquisitions for rejuvenating Big Pharma pipelines. She explains why ...

On today's episode of the Business of Biotech, we're speaking with Sara Bonstein, Chief Financial Officer at Insmed, about what it takes to be a successful CFO. Sara provides useful insights on how to ...

Today we're talking life sciences investment trends and risks with David Sans, an investment banker with an academic background in chemical engineering and molecular modeling, and a professional ...

A prominent national life sciences service company is offering innovative solutions to North Carolina startups by providing access to state-of-the-art facilities in Morrisville. These turnkey spaces ...

North Carolina's life sciences ecosystem is flourishing, largely due to the visionary leadership and innovative spirit of women who are shaping its future. These trailblazers are making significant ...

Ian Thompson, SVP and general manager of U.S. business operations at Amgen, shares his leadership philosophy, what he's ...

Medical affairs can no longer afford to operate within legacy structures. Enter AI-enabled functional service provider (FSP) models that offer operational relief.

Building iteration into the product commercialization process can help life sciences companies avoid many of the missteps ...

Leadership in pharma involves fostering a culture where everyone can thrive. This means questioning assumptions, amplifying diverse voices, and creating environments where authenticity and empathy are ...